Progentior Cell Therapy

From Bench to Market: Advancing the Field of Cellular Therapy

Our quality product service solutions bridge the gaps between technology and patient care by providing custom-tailored cell therapy services, including:

  • Contract Manufacturing
  • Product & Process Development
  • Consulting
  • GTP Services
  • National Distribution
Men standing around talking
 

John P. Gandolfo
Chief Financial Officer
jgandolfo@progenitorcelltherapy.com

Mr. Gandolfo has over 21 years of experience as chief financial officer of rapidly growing private and publicly held companies with a primary focus in the life sciences, healthcare and medical device sectors. He has had direct responsibility over private and public capital raising, financial management, mergers and acquisition transactions and SEC reporting throughout his professional career. His in-depth experience is across corporate finance, M&A, treasury, SEC reporting, corporate operations and Sarbanes Oxley compliance. Mr. Gandolfo has to-date raised approximately $200 million through four initial (“IPO”) and secondary public offerings of common stock and over $85 million through private investors, venture capitalists and convertible debt transactions.

Previous to this appointment, Mr. Gandolfo was Chief Financial Officer of Power Medical Interventions, Inc. (“PMI”), a publicly held medical device company that manufactures and markets computer assisted endo-mechanical surgical instruments. With PMI, Mr. Gandolfo raised approximately $75 million in 2007 through a convertible debt offering and IPO of common stock.

Previous positions include Chief Financial Officer of Bioject Medical Technologies, Inc., a publicly held supplier of needle free drug delivery systems to the pharmaceutical and biotechnology industries, where he was responsible for capital raising and the successful licensing of the Company’s technology to various pharmaceutical companies. For a number of years, Mr. Gandolfo was also Chief Financial Officer and Chief Operating Officer of Impath, Inc, a publicly held cancer information company that provided diagnostic and prognostic cancer analysis to hospitals and pharmaceutical companies. In addition, he was also Chief Financial Officer of Medical Resources, Inc., a publicly held manager of diagnostic imaging centers throughout the United States.

A graduate of Rutgers University, Mr. Gandolfo is a certified public accountant (inactive status) who began his professional career at PricewaterhouseCoopers.